NEW YORK, Dec. 19, 2022/PRNewswire — DarioHealth Corp. (NASDAQ: DIO) (the “Company”) is a market leading player in the world’s electronic therapeutics (DTx) marketplace, has announced that it has published a brand new report in the journal of peer review Frontiers in Physiology today demonstrating the efficacy of the Company’s muscle-skeletal treatment, which employs biofeedback in real-time and behavior-training to ease back pain.

DarioHealth Logo

Dario Move’s posture-training solution aids users in improving their posture using a wearable biofeedback device as well as real-time data feedback within the solution’s application. The device assists in training users by triggering a vibration while the wearer is slumping in a position to help develop awareness and the ability to adopt a proper posture.

The study used the data from 981 people who had that used Dario Move’s posture-training device for a minimum of eight weeks to study the connection between the time spent in training, the use of the device , as well as decreases in back level of pain. The study looked at the data collected by the users at the end of eight weeks exercise and discovered significant clinical effects:

  • Users reported an average 50% less the pain.

  • 60 percent of users experienced significant reduction in pain after just 4 weeks of biofeedback.

  • The majority of patients reported some relief from pain within 8 weeks.

  • The perception of posture quality is significantly related to the effects of weekly duration of exercise on level of pain.

“Addressing chronic pain through the practice of posture is believed to have positive effects on pain. However, now we have the ability to more clearly define the connection and the function that the sensor plays in. We are delighted to demonstrate our capability to utilize the real-time information from the sensor to promote healthier physical and musculoskeletal wellness through continuous training that is positively connected to the clinical outcomes” stated Yifat Hershcovitz PhD. Vice Director of Scientific and Clinical Relations at Dario.

“Dario’s demonstrated ability to alter behavior using real-time information can transform how people manage their health which is a field that holds great potential for helping people. We’re excited to share the latest findings and increase our understanding of how the latest technologies can play a crucial part in forming healthier habits and better health.” added Omar Manejwala, MD Director of Medical Affairs at Dario.

You can read the complete study here.

More About DarioHealth Corp.

DarioHealth Corp. (NASDAQ: DRIO) is an industry-leading Digital Therapeutics (DTx) company that is revolutionizing the way patients with chronic diseases manage their health by implementing the multi-chronic conditions platform designed by users. Our platform and its suite of solutions provide individualized and dynamic treatments powered by data analytics as well as one-on-one coaching to help with hypertension, diabetes as well as muscular skeletal pain, weight management and mental health.

Our platform for users provides ongoing and personalized health care, reversing the traditional approach of healthcare that is episodic. This approach allows patients to change their lifestyles holistically to sustainably change their behavior which results in remarkable user satisfaction as well as retention and outcomes. Doing the right thing is to do is easy to do.

Dario offers its highly evaluated solutions worldwide to health insurance companies and other payers, self-insured employers health care providers, as well as directly to the consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit

Cautionary Note on Forward-Looking Statements

The news release as well as the statements made by the partners and representatives of DarioHealth Corporation. that are related to it include or could contain forward-looking statements as defined by the terms of the Private Securities Litigation Reform Act of 1995. Any statements that are not based on the assertion of fact can be considered as forward-looking statements. For instance this press release Company uses the term “forward-looking” in its press release, when it describes the benefits that can be derived from using their products and services as well as the belief that new technologies play a crucial role in the formation of healthier habits and improved overall health.. Without limiting the meaning of the preceding, phrases like “plan,” “project,” “potential,” “seek,” “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate” or “continue” are used to indicate forward-looking statements. It is important to note that crucial factors can influence the actual results of the Company and may cause the results to differ substantially from any forward-looking statements which could be included in this press release. The factors that could affect the Company’s performance include, but aren’t restricted to, regulatory approvals, demand for products market acceptance, the effects of competition in prices and products and commercialization or technological challenges as well as the results or failure of trade negotiations with the United States, economic, social, and legal risk, and risk of the inadequacy of the cash reserves currently available. Other factors that could lead to or cause differences between the actual results and the forward-looking statements include, but aren’t only those mentioned within the company’s reports to the U.S. Securities and Exchange Commission. The reader is warned that the actual results (including not limited to the timing of and the results of the Company’s business and regulatory strategies in relation to Dario(tm) as detailed in this report) could differ substantially from those described by the forward-looking information. The Company is not under any obligation to release any forward-looking information in the event of any new information, events in the future or otherwise, unless required by law.

DarioHealth Corporate Contact

Mary Mooney

Vice President Marketing

[email protected]


Media Contact

Scott Stachowiak

[email protected]




View original content:

SOURCE DarioHealth Corp.